share_log

Update On Cannabis M&A: Aurora, TerrAscend, SNDL, Curaleaf, And... A Costly Preferred Stock Raise?

Benzinga Real-time News ·  Sep 1, 2022 20:36

On Thursday, analystPablo ZuanicfromCantor Fitzgeraldoffered an industry update on four recent M&A deals andGlasshouse Series B Preferred stock issuance.

Highlights

  • Zuanic said the deal betweenCuraleaf Holdings Inc.(NASDAQ:CRBLF) andFour20 Pharmastands out from the rest, because it could have the greatest long term strategic implications "especially if Curaleaf international goes for a NASDAQ listing (in the event US MSOs do not have a line of sight on listing themselves)."
  • RegardingSNDL (NASDAQ:SNDL) buying Valens (TSE: VLNS), Zuanic said the deal helps the company develop its Canadian recreational moat, more than doubling...
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment